Project Grant HT94252510989
Award Date 9/30/25
Completion Date 9/29/28
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38105, USA
Similar Awards
- This Project Grant award for $1,340,665.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to St. Jude Children's Research Hospital Inc. The award supports research focused on the FGFR pathway as a lead therapeutic vulnerability in pediatric ependymoma, a type of brain cancer in children. The project will be conducted over 3 years, from September 1, 2023 to August 31, 2026, and aims to advance the development of effective...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,295,000.00 to St. Jude Children's Research Hospital Inc. to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The award period runs from September 1, 2024 to August 31, 2028. This research project builds upon St. Jude's extensive experience in pediatric cancer and other life-threatening diseases in...
- This $980,501 Project Grant was awarded on June 15, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to St. Jude Children's Research Hospital Inc. The grant supports advanced biomedical research focused on "CELL INTRINSIC AND EXTRINSIC MODIFIERS OF BMF PROGRESSION IN SAMD9L SYNDROMES" with a performance period from June 15, 2025 to June 14, 2028. As a renowned pediatric treatment and research institution, St. Jude Children's...
- The U.S. Defense Health Agency awarded a $1,036,000 Project Grant to St. Jude Children's Research Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420) to support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant, which runs from November 1, 2025 to October 31, 2029, will fund research to identify NEK5 as a hidden driver in kidney cancer. As a renowned nonprofit pediatric...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $591,248 Project Grant to St. Jude Children's Research Hospital Inc. to conduct research on "SMARCAL1: A UNIQUE TARGET IN ALT-POSITIVE PEDIATRIC SOLID TUMORS." The project will run from September 30, 2024 to September 29, 2026. As part of this grant, St. Jude Children's Research Hospital Inc. will be collaborating with Icahn School of Medicine at Mount Sinai as a...
- This Project Grant award of $728,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by St. Jude Children's Research Hospital Inc. on XPO1 as a therapeutic target in ZFTA-RELA-driven ependymoma. The two-year award, running from September 1, 2023 to August 31, 2025, will fund medical research to investigate XPO1 as a potential treatment for this rare pediatric brain cancer. The research focuses on...
- The Project Grant award of $624,000 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program to the Research Institute at Nationwide Children's Hospital. The funding supports a project titled "SPLICING UP PD-L1 FOR IMMUNOTHERAPY ENHANCEMENT IN PEDIATRIC NEURONAL TUMORS" over a two-year period from September 30, 2023 to September 29, 2025. The goal is to conduct research to advance immunotherapy approaches...
- This Project Grant award for $616,710.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the Children's Research Institute in Washington, D.C. in designing effective adoptive immunotherapy for high-risk pediatric medulloblastoma. The research aims to develop a rational combination with MRI-guided focused ultrasound technology to enhance this innovative cancer treatment approach. The award period runs from August 1, 2024...
- This federal Project Grant award in the amount of $767,328.00 was provided by the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) to St. Jude Children's Research Hospital Inc. to support research aimed at developing a novel therapeutic approach for treating neuroblastoma, a deadly childhood cancer. The key focus of this 5-year project is to investigate the efficacy of combining chemotherapy and immunotherapy with the drug indisulam, which selectively degrades the splicing...
- The Department of Defense, through its Military Medical Research and Development program (CFDA 12.420), awarded a $624,000 project grant to the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The 2-year grant, which began on September 1, 2025, will support comprehensive in vivo phenotyping research on fusion-driven pediatric rhabdomyosarcomas. The Research Institute, a leading pediatric research organization, will leverage its expertise in advanced biomedical research and...